NCT05477277 Adverse Outcomes and Mortality in Liver Transplant
| NCT ID | NCT05477277 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | End Stage Liver DIsease |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-11-02 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2022-11-02 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.
Eligibility Criteria
Inclusion Criteria: 1. All patients with end-stage liver disease undergoing evaluation for liver transplantation 2. Patient clinically indicated for MRI during transplant candidacy evaluation 3. Adult Exclusion Criteria: 1\. Contra indication to MRI
Contact & Investigator
Elizabet Carey, MD
PRINCIPAL INVESTIGATOR
Mayo Cinic
Frequently Asked Questions
Who can join the NCT05477277 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying End Stage Liver DIsease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05477277 currently recruiting?
Yes, NCT05477277 is actively recruiting participants. Contact the research team at bunkley.latasha@mayo.edu for enrollment information.
Where is the NCT05477277 trial being conducted?
This trial is being conducted at Phoenix, United States.
Who is sponsoring the NCT05477277 clinical trial?
NCT05477277 is sponsored by Mayo Clinic. The principal investigator is Elizabet Carey, MD at Mayo Cinic. The trial plans to enroll 100 participants.